AbbVie's Covid-19 antibody partner wraps $221M Hong Kong IPO
Just a few days after AbbVie went all in on a Covid-19 antibody, its partner has officially wrapped its IPO.
Listing on the Hong …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.